
    
      Identification of patients with myeloproliferative neoplasms and aquagenic pruritus.
      Evaluation of the intensity of the aquagenic pruritus. Patients with value >5/10 on the VAS
      (Visual Analogue Scale ) are proposed to participate to the protocole. Randomization between
      the two treatments. Duration of the treatment : 14 days. Regular evaluation of efficacity of
      the drugs (questionnaires). Evaluations will stop 2 months after the last intake. Blood
      samples will be collected before and after the intakes to study cytokine and neuropeptide
      levels.
    
  